Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Summary
Allogeneic hematopoietic cell transplantation may be considered medically necessary to treat chronic lymphocytic leukemia or small lymphocytic lymphoma in individuals with markers of poor-risk disease. Autologous hematopoietic cell transplantation is considered investigational to treat chronic lymphocytic leukemia or small lymphocytic lymphoma, and allogeneic transplantation is considered investigational for these conditions except as noted above. No benefits will be provided for a covered transplant procedure or a transplant evaluation unless the member receives prior authorization through Case Management from Blue Cross & Blue Shield of Mississippi.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.